There are currently 465 clinical trials in Kansas City, Kansas looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Kansas Medical Center, University of Kansas Cancer Center, Kansas University Medical Center and Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Natural History of COVID-19-Related Atrial Fibrillation
NCT04830774
Recruiting
The unCOVer-AF prospective, multicenter registry aims at determining the natural history of atrial fibrillation (AF) via continuous cardiac rhythm monitoring in patients with a first arrhythmic episode during COVID-19 hospitalization.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/15/2021
Locations: Kansas City Heart Rhythm Institute, Overland Park, Kansas City, Kansas
Conditions: COVID-19, Atrial Fibrillation New Onset
Register for Updates
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
NCT04979156
Recruiting
Conventional monopolar or bipolar transurethral resection of bladder tumors is the most common method for resection of a bladder mass. En bloc resection has demonstrated success in the literature utilizing different techniques and lasers, including utilizing the Ho:YAG and Tm:YAG lasers. A recent metanalysis revealed several benefits to laser en bloc resection including less complications and lower recurrence rate.22 Subsequently, laser technology has also advanced with the development of a supe... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/04/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Bladder Cancer, Surgery
Register for Updates
Post COVID-19 Biorepository
NCT04885504
Recruiting
Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Coronavirus Infection
Register for Updates
Function of Circulating Exosomes in Sepsis-induced Immunosuppression
NCT04979767
Recruiting
This is a single-center prospective bio-specimen analysis and observational study aiming to define immune pathways disrupted in bacterial sepsis and to identify clinically useful biomarkers of immune status.
Gender:
All
Ages:
50 years and above
Trial Updated:
07/16/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Sepsis, Septic Shock, Sepsis Syndrome, Sepsis Bacterial, Sepsis, Severe, Sepsis Bacteremia
Register for Updates
Pulmonary Hypertension Biorepository and Registry
NCT04808596
Recruiting
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/27/2021
Locations: The University of Kansas Medical Center, Kansas City, Kansas +1 locations
Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension, Primary, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Primary, 4, Pulmonary Hypertension, Primary, 2, Pulmonary Hypertension, Primary, 3, Chronic Thromboembolic Pulmonary Hypertension
Register for Updates
Evaluation of Multi-Tined Expandable Electrode (MEE) Efficacy and Safety in Treatment of Lumbar Facet Arthropathy by Radiofrequency Neurotomies Compared to Conservative Medical Management.
NCT04730700
Recruiting
The purpose of this study is to better understand how people feel after a radiofrequency ablation standard of care surgery using a different type of needle (multi-tined expandable electrode/MEE) in comparison to receiving conventional medical management (CMM) techniques.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/06/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Chronic Low-back Pain
Register for Updates
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
NCT03250338
Recruiting
This is a randomized, multi-center, double-blind, placebo-controlled study designed to evaluate the efficacy of crenolanib administered following salvage chemotherapy, consolidation chemotherapy, post bone marrow transplantation and as maintenance in relapsed/refractory AML subjects with FLT3 activating mutation.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
04/28/2021
Locations: Kansas University, Kansas City, Kansas
Conditions: Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
Register for Updates
Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain
NCT04598035
Recruiting
The purpose of the ESCAPE Study is to determine the extent to which epidural spinal cord stimulation (SCS) reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension. We also aim to determine the extent to which higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS implant. This is an observational study of patients undergoing an implantation of a SCS device.
Gender:
All
Ages:
Between 30 years and 89 years
Trial Updated:
01/28/2021
Locations: The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center, Kansas City, Kansas
Conditions: Chronic Pain, Hypertension, Implanted Stimulation Electrodes
Register for Updates
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML
NCT03258931
Recruiting
A phase III randomized multi-center study designed to compare the efficacy of crenolanib with that of midostaurin when administered following induction chemotherapy, consolidation chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. About 510 subjects will be randomized in a 1:1 ratio to receive either crenolanib in addition to standard first line treatment of AML (chemotherapy and if eligible, transplantation) (arm A) or midostaurin and standard treat... Read More
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
05/21/2020
Locations: University of Kansas, Kansas City, Kansas
Conditions: Newly Diagnosed FLT3 Mutated AML
Register for Updates